《HDACs在正常和恶性造血中的作用》勘误
Correction to: Role of HDACs in normal and malignant hematopoiesis.
作者信息
Wang Pan, Wang Zi, Liu Jing
机构信息
Hepatobiliary and Enteric Surgery Research Center, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China.
Molecular Biology Research Center and Hunan Province Key Laboratory of Basic and Applied Hematology, School of Life Sciences, Central South University, Changsha, 410078, Hunan, China.
出版信息
Mol Cancer. 2020 Mar 12;19(1):55. doi: 10.1186/s12943-020-01182-w.
Abstract
After the publication of this work [1], the authors note that there are no figure legends in published paper.
摘要
在这项工作[1]发表之后，作者们注意到已发表的论文中没有图注。
相似文献
1
Correction to: Role of HDACs in normal and malignant hematopoiesis.《HDACs在正常和恶性造血中的作用》勘误
Mol Cancer. 2020 Mar 12;19(1):55. doi: 10.1186/s12943-020-01182-w.
2
Correction to: Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab.对《靶向非小细胞肺癌细胞中的表皮生长因子受体：RNA干扰与酪氨酸激酶抑制剂或西妥昔单抗联合应用的效果》一文的更正
BMC Med. 2020 Feb 1;18(1):29. doi: 10.1186/s12916-020-1501-8.
3
Correction to: Short-term dietary restriction in old mice rejuvenates the aging-induced structural imbalance of gut microbiota.对《老年小鼠短期饮食限制可恢复衰老引起的肠道微生物群结构失衡》一文的修正
Biogerontology. 2019 Dec;20(6):849-855. doi: 10.1007/s10522-019-09831-4.
4
Correction to: Engineered atherosclerosis-specific zinc ferrite nanocomplex-based MRI contrast agents.对《工程化的基于动脉粥样硬化特异性锌铁氧体纳米复合物的磁共振成像造影剂》的更正
J Nanobiotechnology. 2019 Feb 28;17(1):33. doi: 10.1186/s12951-019-0443-9.
5
Correction to: Forkhead Box F1 promotes breast cancer cell migration by upregulating lysyl oxidase and suppressing Smad2/3 signaling.对《叉头框蛋白F1通过上调赖氨酰氧化酶和抑制Smad2/3信号促进乳腺癌细胞迁移》一文的更正
BMC Cancer. 2020 Jan 23;20(1):55. doi: 10.1186/s12885-020-6552-x.
6
Correction: Nielson et al. Similarity Downselection: Finding the Most Dissimilar Molecular Conformers for Reference-Free Metabolomics. 2023, , 105.更正：尼尔森等人。相似性下选：为无参考代谢组学寻找最不相似的分子构象。2023年，，105。
Metabolites. 2023 Nov 17;13(11):1158. doi: 10.3390/metabo13111158.
7
Author Correction: Eosinophil differentiation in the bone marrow is promoted by protein tyrosine phosphatase SHP2.作者更正：骨髓中的嗜酸性粒细胞分化由蛋白酪氨酸磷酸酶SHP2促进。
Cell Death Differ. 2019 Sep;26(9):1859-1860. doi: 10.1038/s41418-018-0247-8.
8
Correction to: Bisphenol-A Mediated Inhibition of Hippocampal Neurogenesis Attenuated by Curcumin via Canonical Wnt Pathway.对《姜黄素通过经典Wnt信号通路减轻双酚A介导的海马神经发生抑制》一文的修正
Mol Neurobiol. 2019 Sep;56(9):6660-6662. doi: 10.1007/s12035-019-01685-8.
9
Retracted: Resveratrol inhibits oesophageal adenocarcinoma cell proliferation via AMP-activated protein kinase signaling.撤回：白藜芦醇通过AMP激活的蛋白激酶信号通路抑制食管腺癌细胞增殖。
Asian Pac J Cancer Prev. 2017 Nov 24;18(10):2895-2895. doi: 10.22034/apjcp.2017.18.10.2895.
10
Correction to: Multiple selective sweeps of ancient polymorphisms in and around LTα located in the MHC class III region on chromosome 6.对《6号染色体上MHC III类区域中LTα及其周围古老多态性的多次选择性扫描》的修正
BMC Evol Biol. 2019 Dec 16;19(1):225. doi: 10.1186/s12862-019-1557-2.
引用本文的文献
1
Emerging Neuroprotective Strategies: Unraveling the Potential of HDAC Inhibitors in Traumatic Brain Injury Management.新兴神经保护策略：揭开 HDAC 抑制剂在创伤性脑损伤治疗中的潜力。
Curr Neuropharmacol. 2024;22(14):2298-2313. doi: 10.2174/1570159X22666240128002056.
2
HDAC11, an emerging therapeutic target for metabolic disorders.HDAC11，代谢紊乱的新兴治疗靶点。
Front Endocrinol (Lausanne). 2022 Oct 20;13:989305. doi: 10.3389/fendo.2022.989305. eCollection 2022.
3
Oral HDAC inhibitor tucidinostat in patients with relapsed or refractory peripheral T-cell lymphoma: phase IIb results.口服 HDAC 抑制剂 tucidinostat 治疗复发或难治性外周 T 细胞淋巴瘤：Ⅱb 期结果。
Haematologica. 2023 Mar 1;108(3):811-821. doi: 10.3324/haematol.2022.280996.
本文引用的文献
1
Role of HDACs in normal and malignant hematopoiesis.组蛋白去乙酰化酶在正常和恶性造血中的作用。
Mol Cancer. 2020 Jan 7;19(1):5. doi: 10.1186/s12943-019-1127-7.
Zotero 插件